How Covid-19 vaccines are being weaponised as countries jostle for influence

‘A new hybrid Cold War is underway, with US, China and pivotal states engaging in a power play, says NUS Business School’s Alex Capri...

‘[V]accine diplomacy has shed light on an even more fundamental truth: A hybrid cold war is underway, involving the US, China and other pivotal states. Its by-product is hybrid warfare, a mix of diplomatic, economic, cyber and information-related actions, all of which fall below the threshold of armed conflict but are, nonetheless, disruptive to the workings of the international system.

‘There will be no returning to the kind of globalisation the world experienced over the past four decades. Consequently, state and non-state actors must adapt.’

Read here (Channel News Asia, Apr 8, 2021)

Power jab: The rise of vaccine diplomacy

‘At the end of January the President of Chile, Sebastián Piñera, gave a speech on the tarmac of Santiago airport. ‘Today is a day of joy, excitement and hope,’ he said, standing in front of a Boeing 787 which had just arrived from Beijing. Inside it were two million vaccine doses produced by the Chinese company Sinovac. It was the first of two similar-sized shipments arriving that month.

‘A few days earlier, the President of Mexico, Andrés Manuel López Obrador, had emerged from Covid confinement to thank a ‘genuinely affectionate’ Vladimir Putin for pledging 24 million Sputnik doses to Mexico in the coming months. Hopes of vaccinating his country with the Pfizer vaccine had dissipated when supply dried up. Pfizer blamed ‘global shortages’, but here was the perfect opportunity for Putin to play the hero and to send the world a message: in times of need, Moscow, not Washington, saves the day.

‘This is vaccine diplomacy, the new great game. Nations which are hungry to compete with the West — and especially America — are using their homegrown coronavirus vaccines as a way of gaining influence. They are exchanging their vaccines for loyalty and acts of public obeisance.’

Read here (The Spectator, Feb 20, 2021)

Anatomy of a conspiracy: With Covid, China took leading role

‘From Beijing and Washington to Moscow and Tehran, political leaders and allied media effectively functioned as superspreaders, using their stature to amplify politically expedient conspiracies already in circulation. But it was China -- not Russia – that took the lead in spreading foreign disinformation about COVID-19’s origins, as it came under attack for its early handling of the outbreak.

‘A nine-month Associated Press investigation of state-sponsored disinformation conducted in collaboration with the Atlantic Council’s Digital Forensic Research Lab, shows how a rumor that the U.S. created the virus that causes COVID-19 was weaponized by the Chinese government, spreading from the dark corners of the Internet to millions across the globe. The analysis was based on a review of millions of social media postings and articles on Twitter, Facebook, VK, Weibo, WeChat, YouTube, Telegram and other platforms.’

Read here (Associated Press, Feb 15, 2021)

China, Russia steal a vaccine diplomacy march

‘Russia and China are rising to the rich versus poor challenge by supplying much-needed vaccines to nations that would otherwise be far down on the global list. While the US and EU remain preoccupied with their own Covid-19 problems, Russian and Chinese companies are forming partnerships with each other and countries around the world.

‘That “vaccine diplomacy” success, however, is already starting to raise concerns in the West. Russia’s Sputnik V vaccine, originally poo-pooed in the West as a mere publicity stunt by President Vladimir Putin, has not only proved to be one of the most effective vaccines – providing over 90% protection – but also is inexpensive and easy to use...

‘Until recently, China’s vaccine industry was considered a relatively minor player on the international scene. But the race to develop and deploy Covid-19 vaccines has provided China the impetus to massively upgrade its capacities while establishing itself as a major global supplier. 

‘Covid-19 vaccines by at least four Chinese producers are in final, Phase III trials in a dozen countries, with more in the pipeline. More importantly, the two presently leading Chinese vaccines, produced by the Sinovac and Sinopharm companies, have already been administered to many millions of people in emergency vaccination campaigns in the developing world.’ 

Read here (Asia Times, Feb 8, 2021)

It’s time to trust China’s and Russia’s vaccines

‘The fact is that no Covid-19 vaccine has been developed or released as transparently as it should have been. And while China and Russia may have botched their rollouts more than some Western companies, that doesn’t necessarily mean their vaccines are shoddy. The mounting evidence showing that the Chinese and Russian vaccines are reliable should be taken seriously, and fast, especially considering supply issues throughout the world...

‘What’s more, most big pharmaceutical companies in the West have resisted licensing their vaccines to non-Western manufacturers, and several wealthy countries are blocking a proposal by India and South Africa that the World Trade Organization temporarily suspend some intellectual property protections for Covid-19-related vaccines and treatments.

‘On the other hand, according to our latest analysis of data provided by the analytics firm Airfinity, Sinovac has already signed deals to export this year more than 350 million doses of its vaccine to 12 countries; Sinopharm, around 194 million doses to 11 countries; Sputnik V, about 400 million doses to 17 countries. All three manufacturers have stated publicly that they will have the capacity to produce up to 1 billion doses each in 2021. And all three have licensed their vaccines to local manufacturers in several countries.’

Read here (New York Times, Feb 5, 2021)

Chinese and Russian vaccines in high demand as world scrambles for doses

‘Sales represent coup for Beijing and Moscow, even as concerns over pharma standards linger... 

‘Chinese and Russian manufacturers are seeing growing appetite from foreign buyers for their Covid-19 vaccines as the international scramble for jabs intensifies, despite lingering concerns over incomplete trial data and the rigour of domestic approval processes.

‘Russia’s Gamaleya Research Institute of Epidemiology and Microbiology has agreed to sell its Sputnik V vaccine to countries including Algeria, Argentina, Saudi Arabia and Brazil, while the two leading Chinese manufacturers, Sinopharm and Sinovac Biotech, have signed deals with more than a dozen countries including Bahrain, United Arab Emirates, Egypt, Philippines, Indonesia and Hungary.’

Read here  (Financial Times, Jan 18, 2021) 

After months of bashing Russia’s Sputnik V vaccine, Western journalists in Moscow line up to be inoculated against Covid-19

‘Since Russian President Vladimir Putin announced the registration of Sputnik V, the world's first vaccine against Covid-19, sections of the Western media have taken aim at a formula they’ve dubbed both dangerous and ineffective. However, in recent weeks, Moscow-based representatives of the very same outlets have lined up to receive the much-maligned Sputnik V. Living in Russia, it is no surprise that the correspondents have a much more realistic view of the country than their New York and London-based superiors.

‘On Friday, the New York Times’ Andrew Kramer revealed he had received his first dose of Sputnik V, praising the “bona fide accomplishment for Russian scientists continuing a long and storied practice of vaccine development,” even noting that Moscow has avoided some of the logistical problems seen in the West.’

Read here (RT, Jan 14, 2021)

Covid: Trials to test combination of Oxford and Sputnik vaccines

‘UK and Russian scientists are teaming up to trial a combination of the Oxford-AstraZeneca and Sputnik V vaccines to see if protection against Covid-19 can be improved. Mixing two similar vaccines could lead to a better immune response in people. The trials, to be held in Russia, will involve over-18s, although it's not clear how many people will be involved.’

Read here (BBC, Dec 11, 2020)

China and Russia are using coronavirus vaccines to expand their influence. The US is on the sidelines

“Global health and pharmaceutical interventions are getting sucked into balance-of-power politics,” said David Fidler, senior fellow for global health at the Council on Foreign Relations. “For the U.S., this creates geopolitical nightmares, because we are not in the game.” Beijing and Moscow are marshaling the vast powers of their states to develop vaccines for domestic and international use, accompanied by grand claims of scientific and manufacturing prowess. There are critical questions about safety and efficacy — or even how much each country can produce. But, for the moment, those questions are overshadowed in a seller’s market.

Read here (Washington Post, Nov 24, 2020)

The efficacy of the Sputnik V vaccine is 91.4%, based on the second interim analysis

‘The Sputnik V vaccine is based on a well-studied human adenoviral vector platform that has proven safe and effective with no long-term side effects in more than 250 clinical trials globally conducted during the past two decades - while the history of the use of human adenoviruses in vaccine development began in 1953. More than 100,000 people have received approved and registered drugs based on human adenoviral vectors. The uniqueness of the Russian vaccine lies in the use of two different human adenoviral vectors which allows for a stronger and longer-term immune response as compared to the vaccines using one and the same vector for two doses.’

Read here (Sputnik V, Nov 23, 2020)

Coronavirus vaccine: Chinese scientists plan joint trials with Russia despite doubts over ‘world-beating’ breakthrough

‘Chinese scientists have offered to carry out joint vaccine trials with their Russian counterparts in what could be seen as a vote of confidence following Moscow’s decision to rush through approval for a Covid-19 vaccine. The plan was announced by China’s top respiratory diseases expert Zhong Nanshan on Sunday during a symposium with Russian scientists. He did not specify which vaccine candidate would be tested or where the trials would take place.’

Read here (South China Morning Post, August 17, 2020) 

Coronavirus vaccine pre-orders top 5 billion doses in worldwide scramble for supplies

‘Although none of the coronavirus vaccines under development has proved its efficacy yet in clinical trials, at least 5.7 billion doses have been pre-ordered around the world. First shipments of a Covid-19 vaccine created by Western laboratories have often been snapped up by the United States. Six vaccines are in phase 3 efficacy trials involving thousands of people. In a surprise announcement, Russian President Vladimir Putin claimed on Tuesday that a vaccine dubbed “Sputnik V” – after the Soviet satellite – conferred “sustainable immunity” against the novel coronavirus.’

Read here (South China Morning Post, August 12, 2020)

Top US infectious disease expert Fauci urges caution on China and Russia Covid-19 vaccines

‘America’s top infectious diseases official has raised concerns over the safety of Covid-19 vaccines being developed by China and Russia as the world scrambles for answers to a pandemic the WHO warned will be felt for decades. Several Chinese companies are at the forefront of the race to develop an immunity to the disease and Russia has set a target date of September to roll out its own vaccine. But US infectious disease expert Anthony Fauci said it was unlikely his country would use any vaccine developed in either country, where regulatory systems are far more opaque than they are in the West.’

Read here (Straits Times, August 3, 2020)

Russian university completes clinical trials of Covid-19 vaccine

Russia has become the first country to have completed clinical trials of a Covid-19 vaccine candidate, after Sechenov University said that it had concluded its study. According to Sechenov University Center for Clinical Research on Medications head and chief researcher Elena Smolyarchuk, study data showed the vaccine candidate’s effectiveness, reported Russian news agency TASS. Smolyarchuk was quoted by the news agency as saying: “The research has been completed and it proved that the vaccine is safe. The volunteers will be discharged on 15 July and 20 July.”

Read here (Clinical Trials Arena, July 13, 2020)

Covid-19 has a grandma, grandpa and great grandpa. Where are they?

‘In an unusual move last weekend, China’s envoy to Moscow, Zhang Hanhui highlighted that the whole story about Covid-19 is only unfolding and there are surprises in store for the world community.  It is inconceivable that Ambassador Zhang spoke without the knowledge of Beijing. Significantly, the Chinese envoy chose the Russian state news agency Tass for making some startling disclosures.’ The Tass story is entitled “Ambassador says coronavirus imported to China, points to genetic sequence as proof”.

Read here (Indian Punchline, April 21, 2020)

Misinformation: China… and now Russia

‘[T]he State Department recently accused Russia of using thousands of social media accounts to spread coronavirus misinformation — including a conspiracy theory that the United States engineered the deadly pandemic.

‘The Kremlin’s audience for open disinformation is surprisingly large. The YouTube videos of RT, Russia’s global television network, average one million views per day, “the highest among news outlets,” according to a U.S. intelligence report. Since the founding of the Russian network in 2005, its videos have received more than four billion views, analysts recently concluded.’

Read here (New York Times, April 13, 2020)